From Earlier, AmerisourceBergen Signs Three Year Pharmaceutical Supply Agreement with Express Scripts
AmerisourceBergen Corporation (NYSE: ABC) today announced that it has signed a three year agreement to supply approximately $18.5 billion in pharmaceuticals to Express Scripts (NASDAQ: ESRX) on an annual basis. The agreement is effective October 1, 2012.
“We are honored that Express Scripts has chosen AmerisourceBergen to supply the brand pharmaceuticals it needs for its recently combined mail order and specialty pharmacy business,” said Steven H. Collis, AmerisourceBergen President and Chief Executive Officer.
The contract is expected to contribute approximately 23 percent of the Company's revenues, and about 3 percent of its earnings per share. The contract award has no impact on the Company's expectations for fiscal 2012 or on its preliminary expectations for fiscal 2013 which it disclosed on July 26, 2012.
(c) 2013 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.